Ramon Bataller
@rabataller
Chair, Liver Unit, Hospital Clinic, Barcelona.
Happy to share with you our review on ALCOHOL-ASSOCIATED HEPATITIS, published today in the @NEJM. We dedicate it to all our patients. We will continue to work together to beat it. @Dr_Vijay_Shah @juanpabloarab bit.ly/3jBU16R #LiverTwitter #MedTwitter

CIRROXABAN Study is finally here! 🔬 First DB RCT evaluating rivaroxaban in cirrhosis 💡 Complication-free survival benefit in Child‑Pugh B7 (HR 0.26 [95 % CI 0.07–0.90]). ⚠️ Mild bleeding ↑, but no increase in severe events. 📄 journal-of-hepatology.eu/article/S0168-…
Ciao Jaume, goodbye cariño mio. You have been such a special and wonderful man and I will love you forever.
With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.

As a health provider, I witness daily how precious and fragile life is. Yet globally, we’re investing more in learning how to kill than how to heal. More tanks and missiles than medicines and research. Think about it. It’s not OK.

Two key points that we need to remember about the new SLD (Steatotic Liver Disease) nomenclature: 1️⃣ SLD ≠ MASLD — it also includes Alcohol-Related Liver Disease (ALD). 2️⃣ A person with metabolic syndrome + 10 drinks/day has ALD, not MetALD. @AASLDtweets @EASLedu @AEEHLiver
Rapid weight loss increases the risk of gallstone formation.
Meta-analysis of GLP-1RAs and gastrointestinal adverse events. GLP-1RAs are associated with an increased risk of cholelithiasis and GERD, but do not appear to increase the risk of other gastrointestinal or biliary adverse events. gastrojournal.org/article/S0016-…
Just released: the @USNews 2025 global rankings of the World’s Best Universities. Proud to share that we’re ranked #3 worldwide in Gastroenterology & Hepatology! Huge thanks to our clinicians, researchers, students, and staff—this recognition belongs to all of you.

JUST OUT: "The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021)" In 2021, MASLD had a prevalence of 1.27 billion people while T2DM had a prevalence of 0.51 billion people worldwide. onlinelibrary.wiley.com/doi/10.1002/ue… #LiverTwitter @PojsakornDan
#GUTImage from the #RecentAdvancesInBasicScience paper by De Martin et al entitled "Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events" via bit.ly/4knK3ka #ICI #Liver
Why do two people drinking 10 beers/day have such different GGT levels—one at 85, the other at 980? Genetics matter: variants in GGT and ADRB2 genes regulate GGT levels and activity. Also remember: GGT isn’t just a marker—it’s a pro-oxidant enzyme contributing to liver damage.
Happy to share this RCT from @LiverGALAXY in people with ALD Out today in @NaturePortfolio rdcu.be/eujFT The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
#MASLD➡️Not just Western and not just in adults. Scary data for our future unless we act now! @AmCollegeGastro @NASH_and_coffee @GlobalLiver @juanpabloarab
Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children Qiao, et al. 📕 bit.ly/4eb7MBX @MLongMD @JasmohanBajaj @JazzminZheng
Today, @NEJM reports that Efruxifermin (an FGF21 agonist) is the first drug to reduce fibrosis in compensated cirrhosis due to NASH. This effect is seen after 96 weeks, so patience is key. Could combining Semaglutide make it even more powerful?

How does transient elastography (TE) ⬇️alcohol use? In our new study, @sm_rutledge & @ronathaniMD examined potential mechanisms behind this & found that TE ⬆️readiness for change. Start thinking of TE as a #theranostic intervention. doi.org/10.1111/adb.70… @Echosens
Important slide from @lykhaque on the importance of language From Research Society on Alcohol Conference
A basic way to avoid bad habits is to imagine how you’ll feel afterward. It’s called episodic future thinking. Previewing the unwanted consequences of procrastinating, overeating, and doomscrolling can motivate better choices. Your future self is wiser than your present self.
II JORNADAS DE CASOS DE USO DE LA INTELIGENCIA ARTIFICIAL GENERATIVA EN MEDICINA DE LA UNIVERSITAT DE BARCELONA 🔥 Ya están aquí. Nuestras II Jornadas de Casos de Uso de IAgen en Medicina y Ciencias de la Salud, que cierran el segundo Experto del programa de Máster IACS-UB de la…
Fantastic work led by @JIFortea 1⃣In compensated cirrhosis, carvedilol reduced the risk of first decompensation. 2⃣In decompensated cirrhosis, carvedilol reduced the risk of further decompensation. @sepdigestiva @AEEHLiver @EASLnews @AASLDtweets sciencedirect.com/science/articl…
🔸1 in 10 school age children in US has Fetal Alcohol Syndrome 🔸29 million in US with Alcohol Use Disorder 🔸5% of cancers associated with alcohol 🔸Alcohol-associated liver disease 📈 We desperately need research funding for @NIAAAnews to prevent these harms @juanpabloarab
🟪NEW Article in press❕ GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #hepatitis #LiverX #LiverTwitter @rabataller